APO Research
Talk to an analyst

APO RESEARCH · REPORT

Doripenem

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Doripenem Market Analysis and Forecast 2026-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchDoripenem Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Doripenem Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Doripenem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Doripenem Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Doripenem Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Doripenem market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Doripenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Doripenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Doripenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Doripenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Doripenem include Janssen, Shionogi and Apotex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Doripenem, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Doripenem, also provides the revenue of main regions and countries. Of the upcoming market potential for Doripenem, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Doripenem revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Doripenem market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Doripenem revenue, projected growth trends, production technology, application and end-user industry.

Doripenem Segment by Company

Janssen

Shionogi

Apotex

Doripenem Segment by Type

500 mg single-use vial

250 mg single-use vial

Doripenem Segment by Application

Hospital

Drug store

Doripenem Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Doripenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Doripenem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Doripenem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Doripenem in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Doripenem company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Doripenem revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Doripenem Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 500 mg single-use vial Major Player Table 3. 250 mg single-use vial Major Player Table 4. Global Doripenem Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Drug store Major Player Table 7. Doripenem Industry Trends Table 8. Doripenem Industry Drivers Table 9. Doripenem Industry Opportunities and Challenges Table 10. Doripenem Industry Restraints Table 11. Global Doripenem Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Doripenem Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Doripenem Market Share by Region (2021-2026) Table 14. Global Doripenem Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Doripenem Market Share by Region (2027-2032) Table 16. Global Doripenem Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Doripenem Revenue Market Share by Players (2021-2026) Table 18. Global Doripenem Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Doripenem Key Players Headquarters & Area Served Table 20. Global Doripenem Players, Product Type & Application Table 21. Global Doripenem Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Doripenem by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Doripenem Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Doripenem Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Doripenem Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Doripenem Revenue Market Share by Type (2021-2026) Table 28. Global Doripenem Revenue Market Share by Type (2027-2032) Table 29. Global Doripenem Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Doripenem Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Doripenem Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Doripenem Revenue Market Share by Application (2021-2026) Table 33. Global Doripenem Revenue Market Share by Application (2027-2032) Table 34. Janssen Company Information Table 35. Janssen Business Overview Table 36. Janssen Doripenem Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Janssen Doripenem Product Portfolio Table 38. Janssen Recent Development Table 39. Shionogi Company Information Table 40. Shionogi Business Overview Table 41. Shionogi Doripenem Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Shionogi Doripenem Product Portfolio Table 43. Shionogi Recent Development Table 44. Apotex Company Information Table 45. Apotex Business Overview Table 46. Apotex Doripenem Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Apotex Doripenem Product Portfolio Table 48. Apotex Recent Development Table 49. North America Doripenem Revenue by Type (2021-2026) & (US$ Million) Table 50. North America Doripenem Revenue by Type (2027-2032) & (US$ Million) Table 51. North America Doripenem Revenue by Application (2021-2026) & (US$ Million) Table 52. North America Doripenem Revenue by Application (2027-2032) & (US$ Million) Table 53. North America Doripenem Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America Doripenem Revenue by Country (2021-2026) & (US$ Million) Table 55. North America Doripenem Revenue by Country (US$ Million) & (2027-2032) Table 56. Europe Doripenem Revenue by Type (2021-2026) & (US$ Million) Table 57. Europe Doripenem Revenue by Type (2027-2032) & (US$ Million) Table 58. Europe Doripenem Revenue by Application (2021-2026) & (US$ Million) Table 59. Europe Doripenem Revenue by Application (2027-2032) & (US$ Million) Table 60. Europe Doripenem Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe Doripenem Revenue by Country (2021-2026) & (US$ Million) Table 62. Europe Doripenem Revenue by Country (US$ Million) & (2027-2032) Table 63. China Doripenem Revenue by Type (2021-2026) & (US$ Million) Table 64. China Doripenem Revenue by Type (2027-2032) & (US$ Million) Table 65. China Doripenem Revenue by Application (2021-2026) & (US$ Million) Table 66. China Doripenem Revenue by Application (2027-2032) & (US$ Million) Table 67. Asia Doripenem Revenue by Type (2021-2026) & (US$ Million) Table 68. Asia Doripenem Revenue by Type (2027-2032) & (US$ Million) Table 69. Asia Doripenem Revenue by Application (2021-2026) & (US$ Million) Table 70. Asia Doripenem Revenue by Application (2027-2032) & (US$ Million) Table 71. Asia Doripenem Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia Doripenem Revenue by Region (US$ Million) & (2021-2026) Table 73. Asia Doripenem Revenue by Region (US$ Million) & (2027-2032) Table 74. SAMEA Doripenem Revenue by Type (2021-2026) & (US$ Million) Table 75. SAMEA Doripenem Revenue by Type (2027-2032) & (US$ Million) Table 76. SAMEA Doripenem Revenue by Application (2021-2026) & (US$ Million) Table 77. SAMEA Doripenem Revenue by Application (2027-2032) & (US$ Million) Table 78. SAMEA Doripenem Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. SAMEA Doripenem Revenue by Country (2021-2026) & (US$ Million) Table 80. SAMEA Doripenem Revenue by Country (US$ Million) & (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Doripenem Image Figure 2. Global Doripenem Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Doripenem Market Size Share 2021 VS 2025 VS 2032 Figure 4. 500 mg single-use vial Image Figure 5. 250 mg single-use vial Image Figure 6. Global Doripenem Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Doripenem Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug store Image Figure 10. Global Doripenem Market Size (US$ Million) & (2021-2032) Figure 11. Global Doripenem Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Doripenem Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Doripenem Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Doripenem Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Doripenem Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Doripenem Revenue Market Share by Type (2021-2032) Figure 18. Global Doripenem Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Doripenem Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Doripenem Revenue Market Share by Application (2021-2032) Figure 21. North America Doripenem Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Doripenem Revenue Share by Type (2021-2032) Figure 23. North America Doripenem Revenue Share by Application (2021-2032) Figure 24. North America Doripenem Revenue Share by Country (2021-2032) Figure 25. United States Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Doripenem Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Doripenem Revenue Share by Type (2021-2032) Figure 30. Europe Doripenem Revenue Share by Application (2021-2032) Figure 31. Europe Doripenem Revenue Share by Country (2021-2032) Figure 32. Germany Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Doripenem Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Doripenem Revenue Share by Type (2021-2032) Figure 42. China Doripenem Revenue Share by Application (2021-2032) Figure 43. Asia Doripenem Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Doripenem Revenue Share by Type (2021-2032) Figure 45. Asia Doripenem Revenue Share by Application (2021-2032) Figure 46. Asia Doripenem Revenue Share by Region (2021-2032) Figure 47. Japan Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Doripenem Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Doripenem Revenue Share by Type (2021-2032) Figure 55. SAMEA Doripenem Revenue Share by Application (2021-2032) Figure 56. SAMEA Doripenem Revenue Share by Country (2021-2032) Figure 57. Brazil Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Doripenem Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • 500 mg single-use vial
  • 250 mg single-use vial
Applications
  • Hospital
  • Drug store
Companies covered
  • Janssen
  • Shionogi
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Doripenem Market by Type
  3. 1.2.1 Global Doripenem Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 500 mg single-use vial
  5. 1.2.3 250 mg single-use vial
  6. 1.3 Doripenem Market by Application
  7. 1.3.1 Global Doripenem Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Doripenem Market Dynamics
  1. 2.1 Doripenem Industry Trends
  2. 2.2 Doripenem Industry Drivers
  3. 2.3 Doripenem Industry Opportunities and Challenges
  4. 2.4 Doripenem Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Doripenem Market Perspective (2021-2032)
  2. 3.2 Global Doripenem Growth Trends by Region
  3. 3.2.1 Global Doripenem Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Doripenem Market Size by Region (2021-2026)
  5. 3.2.3 Global Doripenem Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Doripenem Revenue by Players
  2. 4.1.1 Global Doripenem Revenue by Players (2021-2026)
  3. 4.1.2 Global Doripenem Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Doripenem Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Doripenem Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Doripenem Key Players Headquarters & Area Served
  7. 4.4 Global Doripenem Players, Product Type & Application
  8. 4.5 Global Doripenem Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Doripenem Market CR5 and HHI
  11. 4.6.3 2025 Doripenem Tier 1, Tier 2, and Tier 3
5 Doripenem Market Size by Type
  1. 5.1 Global Doripenem Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Doripenem Revenue by Type (2021-2032)
  3. 5.3 Global Doripenem Revenue Market Share by Type (2021-2032)
6 Doripenem Market Size by Application
  1. 6.1 Global Doripenem Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Doripenem Revenue by Application (2021-2032)
  3. 6.3 Global Doripenem Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Janssen
  2. 7.1.1 Janssen Company Information
  3. 7.1.2 Janssen Business Overview
  4. 7.1.3 Janssen Doripenem Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Doripenem Product Portfolio
  6. 7.1.5 Janssen Recent Developments
  7. 7.2 Shionogi
  8. 7.2.1 Shionogi Company Information
  9. 7.2.2 Shionogi Business Overview
  10. 7.2.3 Shionogi Doripenem Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Shionogi Doripenem Product Portfolio
  12. 7.2.5 Shionogi Recent Developments
  13. 7.3 Apotex
  14. 7.3.1 Apotex Company Information
  15. 7.3.2 Apotex Business Overview
  16. 7.3.3 Apotex Doripenem Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Apotex Doripenem Product Portfolio
  18. 7.3.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Doripenem Revenue (2021-2032)
  2. 8.2 North America Doripenem Revenue by Type (2021-2032)
  3. 8.2.1 North America Doripenem Revenue by Type (2021-2026)
  4. 8.2.2 North America Doripenem Revenue by Type (2027-2032)
  5. 8.3 North America Doripenem Revenue Share by Type (2021-2032)
  6. 8.4 North America Doripenem Revenue by Application (2021-2032)
  7. 8.4.1 North America Doripenem Revenue by Application (2021-2026)
  8. 8.4.2 North America Doripenem Revenue by Application (2027-2032)
  9. 8.5 North America Doripenem Revenue Share by Application (2021-2032)
  10. 8.6 North America Doripenem Revenue by Country
  11. 8.6.1 North America Doripenem Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Doripenem Revenue by Country (2021-2026)
  13. 8.6.3 North America Doripenem Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Doripenem Revenue (2021-2032)
  2. 9.2 Europe Doripenem Revenue by Type (2021-2032)
  3. 9.2.1 Europe Doripenem Revenue by Type (2021-2026)
  4. 9.2.2 Europe Doripenem Revenue by Type (2027-2032)
  5. 9.3 Europe Doripenem Revenue Share by Type (2021-2032)
  6. 9.4 Europe Doripenem Revenue by Application (2021-2032)
  7. 9.4.1 Europe Doripenem Revenue by Application (2021-2026)
  8. 9.4.2 Europe Doripenem Revenue by Application (2027-2032)
  9. 9.5 Europe Doripenem Revenue Share by Application (2021-2032)
  10. 9.6 Europe Doripenem Revenue by Country
  11. 9.6.1 Europe Doripenem Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Doripenem Revenue by Country (2021-2026)
  13. 9.6.3 Europe Doripenem Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Doripenem Revenue (2021-2032)
  2. 10.2 China Doripenem Revenue by Type (2021-2032)
  3. 10.2.1 China Doripenem Revenue by Type (2021-2026)
  4. 10.2.2 China Doripenem Revenue by Type (2027-2032)
  5. 10.3 China Doripenem Revenue Share by Type (2021-2032)
  6. 10.4 China Doripenem Revenue by Application (2021-2032)
  7. 10.4.1 China Doripenem Revenue by Application (2021-2026)
  8. 10.4.2 China Doripenem Revenue by Application (2027-2032)
  9. 10.5 China Doripenem Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Doripenem Revenue (2021-2032)
  2. 11.2 Asia Doripenem Revenue by Type (2021-2032)
  3. 11.2.1 Asia Doripenem Revenue by Type (2021-2026)
  4. 11.2.2 Asia Doripenem Revenue by Type (2027-2032)
  5. 11.3 Asia Doripenem Revenue Share by Type (2021-2032)
  6. 11.4 Asia Doripenem Revenue by Application (2021-2032)
  7. 11.4.1 Asia Doripenem Revenue by Application (2021-2026)
  8. 11.4.2 Asia Doripenem Revenue by Application (2027-2032)
  9. 11.5 Asia Doripenem Revenue Share by Application (2021-2032)
  10. 11.6 Asia Doripenem Revenue by Country
  11. 11.6.1 Asia Doripenem Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Doripenem Revenue by Country (2021-2026)
  13. 11.6.3 Asia Doripenem Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Doripenem Revenue (2021-2032)
  2. 12.2 SAMEA Doripenem Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Doripenem Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Doripenem Revenue by Type (2027-2032)
  5. 12.3 SAMEA Doripenem Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Doripenem Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Doripenem Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Doripenem Revenue by Application (2027-2032)
  9. 12.5 SAMEA Doripenem Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Doripenem Revenue by Country
  11. 12.6.1 SAMEA Doripenem Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Doripenem Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Doripenem Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst